Brightsurf Science News & Current Events

June 05, 2016
The scientists found out, that bats are transmitters of infections dangerous for humans
Bats for a long time were not considered as the transmitter of dangerous infections which was a reason why scientists did not study their parasites.

Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma
Children with high-risk neuroblastoma whose treatment included two autologous stem-cell transplants were more likely to be free of cancer three years later than patients who underwent a single transplant, a Phase 3 clinical trial has found, according to research presented at the annual meeting of the American Society of Clinical Oncology.

New drug 'retrains' immune system to fight aggressive bladder cancer
A new drug that harnesses the immune system to attack tumors is highly effective against advanced bladder cancer, according to the results of an international clinical trial to be presented June 5 at the annual meeting of the American Society for Clinical Oncology (ASCO).

Immunotherapy effective against some types of sarcoma
An existing cancer immunotherapy drug reduces tumor size in some types of rare connective tissue cancers, called sarcomas, report researchers at the University of Pittsburgh Cancer Institute.

MD Anderson researchers highlight advances in gynecologic cancer treatments
Advances that could change gynecologic cancer standard-of-care treatments are the centerpiece of key studies being presented by researchers from The University of Texas MD Anderson Cancer Center's Department of Gynecologic Oncology and Reproductive Medicine at the 2016 Annual Meeting of the American Society of Clinical Oncology.

LA BioMed researchers editorialize on new breast cancer study in NEJM
LA BioMed Researchers Rowan T. Chlebowski, MD, PhD, and Matthew J.

GHIT Fund welcomes ten new partnerships
The Global Health Innovative Technology Fund today welcomed ten new funding partnerships that include major global pharmaceutical and biotechnology companies -- collaborations that will expand investments into research and development for neglected diseases worldwide, many of which have already begun to show progress in clinical trials.

Novel targeted drug shows promise against advanced small cell lung cancer
The experimental 'smart-bomb' drug rovalpituzumab tesirine (Rova-T) appears safe and shows efficacy in treating patients with advanced small cell lung cancer, according to results from a first-in-human clinical trial to be presented today by a Memorial Sloan Kettering researcher at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago.

Women and people under the age of 35 at greatest risk of anxiety
Women are almost twice as likely to experience anxiety as men, according to a review of existing scientific literature, led by the University of Cambridge.

Nivolumab immunotherapy helps patients with advanced bladder cancer
The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless of whether their tumors had a biomarker related to the drug's target, according to clinical trial results from The University of Texas MD Anderson Cancer Center.

Nivolumab shows promise in first-ever trial for patients with refractory, metastatic anal cancer
In the first-ever clinical trial for metastatic patients previously treated for the disease, research led by The University of Texas MD Anderson Cancer Center found that the immune checkpoint blockade nivolumab shows promise for the majority of patients with squamous cell carcinoma of the anal canal (SCCA). is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to